12:00 AM
Jun 03, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

EV71 vaccine regulatory update

Sinovac said the Beijing Drug Administration (BDA) accepted for review an NDA for its EV71 vaccine against hand, foot and mouth disease (HFMD)...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >